. 2005 Oct 25;93(9):1011–1018. doi: 10.1038/sj.bjc.6602823

Table 2. Plasma pharmacokinetics of NU7026 and its metabolites NU7199 and NU7200 following administration of NU7026 at 5 mg kg⁻¹ i.v. to mice.

Compound	C_max (nmol l⁻¹)	T_max (h)	AUC last (nmol l h⁻¹)	t_1/2 (h)	Cl obs. (l h⁻¹)	V_d (l)
7026	5123	0	3616	1.22	0.09	0.16
7199	705	0.25	414	0.2	0.82	0.23
7200	293	0.25	143	0.16	2.44	0.55

Parameters are C_max (maximum concentration), AUC (area under the concentration vs time curve), Cl (Clearance), t_1/2 (half-life), V_d (volume ofz distribution based on the elimination phase).

Table 2. Plasma pharmacokinetics of NU7026 and its metabolites NU7199 and NU7200 following administration of NU7026 at 5 mg kg−1 i.v. to mice.

Table 2. Plasma pharmacokinetics of NU7026 and its metabolites NU7199 and NU7200 following administration of NU7026 at 5 mg kg⁻¹ i.v. to mice.